CAS: 3397-35-1; Z-Leu-Osu

该化合物是属于氨基酸衍生物类的化学化合物,具有乳胶基脊椎,是一种必要的氨基酸,经一个苯氧基碳基组的修改,可提高其稳定性和溶性;2,5-二氧-1-丙基丁基酯的出现表明,该物质可能具有独特的再活性和生物活动,有可能在peptide合成中作为药物或中间体;该化合物外表可能白色到非白色,在有机溶剂中可能溶解,视具体情况而定;其结构表明药物的潜在应用,特别是在药物设计和开发中,对氨基酸的修改可导致改善治疗特性;与许多化学物质一样,处理应谨慎进行,遵守安全议定书,以减少与使用氨基酸有关的任何风险.

结构式图片

相似化合物

3392-09-4 76542-83-1 3496-11-5

上下游产品

CAS号6066-82-6 N-羟基琥珀酰亚胺 | CAS号2018-66-8 N-苄氧羰基-L-亮氨酸 | CAS号3303-31-9 (S)-2-((S)-2-氨基... | CAS号2873-36-1 环(L-脯氨酰-L-亮氨酰) | CAS号7801-71-0 N-苄氧羰基-L-亮氨酰-L-亮氨酸 | CAS号83510-60-5 Phenylmethyl (S... | CAS号42537-96-2 (2S,3S)-2-((S)-... | CAS号40290-56-0 Z-Leu-Ser-OMe

合成工艺路线路线简述

    N-羟基丁二酰亚胺,N-苄氧羰基-L-亮氨酸置于n,N'-二环己基碳二亚胺体系中,用 四氢呋喃 作为反应溶剂,化学反应 1.0H,反应生成 Cbz-L-亮氨酸n-羟基琥珀酰亚胺脂
    参考文献:通过蛋白原性侧链有效获得对映体纯的γ4-氨基酸,并研究混合肽螺旋中γ4-Asn和γ4-Ser的结构
    标题:通过蛋白原性侧链有效获得对映体纯的γ4-氨基酸,并研究混合肽螺旋中γ4-Asn和γ4-Ser的结构
    摘要:由α-和β-氨基酸组成的杂合肽最近已成为一类新型的肽折叠剂.相比较而言,γ的组成γ-和混合γ-肽4-氨基酸比其β-对应物少的研究.然而,最近的研究表明,γ 4-氨基酸有较高的倾向折叠成有序的螺旋结构.作为氨基酸侧链的官能团起到生物上下文中的关键作用,本研究的目的是调查γ的有效合成4-残基与官能蛋白原侧链和在混合的肽序列的结构分析.在这里,各种n-末端和c-末端游离-γ的有效和对映体纯合成4-残基,从苄基酯(coobzl)起始ñ-Cbz保护的(ë)-α,报道β不饱和γ氨基通过在单锅催化氢化多个氢解和双键还原酸.8未受保护的γ的结晶构象,4-氨基酸(γ 4-Val,γ 4-Leu,γ 4-Ile,γ 4-Thr(o吨丁基),γ 4-Tyr,γ 4-Asp(o吨卜),γ 4-Glu(o吨丁基),和γ-Aib)显示,这些氨基酸通过一个螺旋利于笨拙沿着中心ç构象γ  ç β键.来研究γ行为4
    DOI:10.1002/chem.201302732

    海关参考信息

    专利信息


    专利号:US-4504415-A
    优先权日:1983-04-04
    标题:Synthesis of thymosin α1 and desacetyl thymosin α1
    发明人:FELIX ARTHUR M; GILLESSEN DIETER; STUDER ROLF; MEIENHOFER JOHANNES A; TRZECIAK ARNOLD
    权利人:HOFFMANN LA ROCHE
    摘要:An improved solution phase synthesis of thymosin alpha 1 and desacetyl thymosin alpha 1 with t-Boc side chain protection and proceeding through novel intermediates is disclosed.

    专利号:US-4517119-A
    优先权日:1983-04-04
    标题:Synthesis of thymosin α1
    发明人:FELIX ARTHUR M; GILLESSEN DIETER; LERGIER WILLIAM; MEIENHOFER JOHANNES A; TRZECIAK ARNOLD
    权利人:HOFFMANN LA ROCHE
    摘要:An improved solution phase synthesis of thymosin α 1 and proceeding through novel intermediates is disclosed.

    专利号:US-3953416-A
    优先权日:1971-12-20
    标 题:Synthetic decapeptide having the activity of the luteinizing hormone releasing hormone and method for manufacturing the same
    发明人:FOLKERS KARL; CURRIE BRUCE L; CHANG JAW-KANG; SIEVERTSSON HANS; BOGENTOFT CONNY
    权利人:FOLKERS KARL; CURRIE BRUCE L; CHANG JAW KANG; SIEVERTSSON HANS; BOGENTOFT CONNY
    摘要:A synthetic decapeptide, L-pglutamyl-L-histidyl-L-tryptophanyl-L-seryl-L-tyrosyl-glycyl-L-leucy l-L-arginyl-L-prolyl-glycinamide which has the hormonal activities of the luteinizing hormone releasing hormone (LRH) of the hypothalamus gland of mammals is produced by utilizing as the key starting materials, the amino acids, glutamic acid or pyroglutamic acid, histidine, tryptophan, serine, tyrosine, glycine, leucine, arginine, and proline. Synthesis of the decapeptide is accomplished by coupling, in appropriate combinations of appropriate protected forms of the amino acids, and finally deprotecting to yield the amide, L-pglutamyl-L-histidyl-L-tryptophanyl-L-seryl-L-tyrosyl-glycyl-L-leucy l-L-arginyl-L-prolyl-glycinamide.

    专利号:US-3725380-A
    优先权日:1969-04-05
    标 题:Method of synthesizing peptides in the presence of a carbodiimide and a 1-hydroxy-benzotriazole
    发明人:KONIG W; GEIGER R
    权利人:HOECHST AG
    摘要:Improved synthesis of peptides by the carbodiimide method in which an amino-protected amino acid or peptide having a reactive carboxy group is condensed with a carboxy-protected amino acid or peptide having a reactive amino group in the presence of a 1hydroxy-benzotriazole or a substituted 1-hydroxy-benzotriazole of the formula AS WELL AS IN THE PRESENCE OF A CARBODIIMIDE SUCH AS DICYCLOHEXYL CARBODIIMIDE.

    专利号:WO-0071569-A1
    优先权日:1999-05-26
    标题 :Minimal isolation peptide synthesis process using ion-exchange resins as scavenging agents
    发明人:TOLLE JOHN C; CALIFANO JEAN-CHRISTOPHE; DHAON MADHUP K; SACHS HOWARD A; BLODGETT JAMES K
    权利人:ABBOTT LAB
    摘要:A process for the production of a polypeptide having a pre-determined number and sequence of amino acid residues, comprising the steps of first exposing a first substrate amino acid or peptide fragment to a stoichiometric excess of a second reactant amino acid or peptide fragment to form a condensation product; second, contacting the reaction solution from the first step with an insoluble scavenger to sequester the excess of the second reactant amino acid or peptide fragment; third, removing from the solution the sequestered excess second reactant amino acid or peptide fragment; fourth, subjecting the reaction solution to a reaction which removes the protecting group from either the N- or C-terminus of the condensation product of the first step; and fifth, if necessary, repeating the first through fourth steps. The method is capable of large-scale production of peptides in solution, is not subject to the one-terminus-only limitation of the solid-phase method, possesses the 'cleanliness' of the solid-phase method and, like the solid-phase method, is capable of automation. Most importantly, however, the method of the present invention does not require the frequent isolation of intermediates in a lengthy synthetic sequence nor, necessarily, the removal of all contaminating by-products from the reaction mixture prior to subsequent processing steps.

    专利号:MX-PA01012082-A
    优先权日:1999-05-26
    标 题 :SYNTHESIS PROCESS OF MINIMUM INSULATION PEPTIDES, USING ION EXCHANGE RESINS AS CLEANING AGENTS.
    常州欣宜晨药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.xycpharm.com
    企业联系电话:0519-85566998👤
    📞常州欣宜晨药业有限公司 ⚠️参考联系方式
    联系人:徐经理
    电话:0519-85566998
    手机:18502571086
    传真:0519-85566998
    邮箱:xycpharm@163.com
    通信地址: 江苏省常州市天宁区劳动东路388号
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常州市天宁区劳动东路388号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/978-3-663-06807-5_9
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知